In this interview, News-Medical talks to Andre Alfaro from nanoComposix (now a Fortis Life Sciences Company) about the possibilities lateral flow assays offer in both the present and potential ...
The government will no longer provide free universal Covid-19 testing for most of the public from 1 April, as part of its plan for living with the virus. While people can currently still order lateral ...
A recent study published on the medRxiv* preprint server discusses the role of lateral flow device (LFD) testing in potentially improving coronavirus disease 2019 (COVID-19) isolation policies. Study: ...
The proportion of COVID-19 infections missed by the Innova lateral flow test (LFT) are “substantial enough to be of clinical importance” according to an analysis published in The BMJ. The study by ...
Today, ams (SIX: AMS), a leading worldwide supplier of high-performance sensor solutions, announces that it has chosen the high-performance cloud infrastructure developed by Extra Horizon to power a ...
The proportion of people with current covid-19 infection missed by the Innova lateral flow test (LFT) is substantial enough to be of clinical importance, particularly when testing people without ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results